Joji Suzuki1,2, Diana Robinson1,2, Matthew Mosquera1,2, Daniel A Solomon2,3, Mary W Montgomery2,3, Christin D Price2,4, Jennifer A Johnson2,3, Bianca Martin1, Jane W Liebschutz5, Jeffrey L Schnipper2,6, Roger D Weiss2,7. 1. Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts. 2. Harvard Medical School, Boston, Massachusetts. 3. Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts. 4. Brigham and Women's Physicians Organization, Boston, Massachusetts. 5. Division of General Internal Medicine, Center for Research on Health Care, University of Pittsburgh, Pittsburgh, Pennsylvania. 6. Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, Massachusetts. 7. Division of Drug and Alcohol Abuse, McLean Hospital, Belmont, Massachusetts.
Abstract
BACKGROUND AND OBJECTIVES: The impact of medications for opioid use disorder (MOUD) on against medical advice (AMA) discharges among people who inject drugs (PWID) hospitalized for endocarditis is unknown. METHODS: A retrospective review of all PWID hospitalized for endocarditis at our institution between 2016 and 2018 (n = 84). RESULTS: PWID engaged with MOUD at admission, compared with those who were not, were less likely to be discharged AMA but this did not reach statistical significance in adjusted analysis (odds ratio [OR], 0.22; 95% confidence interval [CI], 0.033-1.41; P = .11). Among out-of-treatment individuals, newly initiating MOUD did not lead to significantly fewer AMA discharges (OR, 0.98; 95% CI, 0.26-3.7; P = .98). CONCLUSION AND SCIENTIFIC SIGNIFICANCE: PWID hospitalized for endocarditis are at high risk for discharge AMA but more research is needed to understand the impact of MOUD. (Am J Addict 2020;29:155-159).
BACKGROUND AND OBJECTIVES: The impact of medications for opioid use disorder (MOUD) on against medical advice (AMA) discharges among people who inject drugs (PWID) hospitalized for endocarditis is unknown. METHODS: A retrospective review of all PWID hospitalized for endocarditis at our institution between 2016 and 2018 (n = 84). RESULTS: PWID engaged with MOUD at admission, compared with those who were not, were less likely to be discharged AMA but this did not reach statistical significance in adjusted analysis (odds ratio [OR], 0.22; 95% confidence interval [CI], 0.033-1.41; P = .11). Among out-of-treatment individuals, newly initiating MOUD did not lead to significantly fewer AMA discharges (OR, 0.98; 95% CI, 0.26-3.7; P = .98). CONCLUSION AND SCIENTIFIC SIGNIFICANCE: PWID hospitalized for endocarditis are at high risk for discharge AMA but more research is needed to understand the impact of MOUD. (Am J Addict 2020;29:155-159).
Authors: Eberechukwu Onukwugha; Elijah Saunders; C Daniel Mullins; Françoise G Pradel; Marni Zuckerman; Matthew R Weir Journal: Qual Saf Health Care Date: 2010-06-09
Authors: Sarah E Rudasill; Yas Sanaiha; Alexandra L Mardock; Habib Khoury; Hanning Xing; James W Antonios; James A McKinnell; Peyman Benharash Journal: J Am Coll Cardiol Date: 2019-02-12 Impact factor: 24.094
Authors: Laura R Marks; Satish Munigala; David K Warren; Stephen Y Liang; Evan S Schwarz; Michael J Durkin Journal: Clin Infect Dis Date: 2019-05-17 Impact factor: 9.079
Authors: Elana S Rosenthal; Adolf W Karchmer; Jesse Theisen-Toupal; Roger Araujo Castillo; Chris F Rowley Journal: Am J Med Date: 2015-11-18 Impact factor: 4.965
Authors: Alysse G Wurcel; Jordan E Anderson; Kenneth K H Chui; Sally Skinner; Tamsin A Knox; David R Snydman; Thomas J Stopka Journal: Open Forum Infect Dis Date: 2016-07-26 Impact factor: 3.835
Authors: Ayesha Appa; Meredith Adamo; Stephenie Le; Jennifer Davis; Lisa Winston; Sarah B Doernberg; Henry Chambers; Marlene Martin; Nancy K Hills; Phillip O Coffin; Vivek Jain Journal: Clin Infect Dis Date: 2022-01-29 Impact factor: 9.079
Authors: Maria A Corcorran; Jenell Stewart; Kristine Lan; Ayushi Gupta; Sara N Glick; Chetan Seshadri; Kevin J Koomalsingh; Edward F Gibbons; Robert D Harrington; Shireesha Dhanireddy; H Nina Kim Journal: Open Forum Infect Dis Date: 2022-03-29 Impact factor: 4.423
Authors: Katelyn F McNamara; Breanne E Biondi; Raúl U Hernández-Ramírez; Noor Taweh; Alyssa A Grimshaw; Sandra A Springer Journal: Open Forum Infect Dis Date: 2021-06-02 Impact factor: 3.835
Authors: Susan L Calcaterra; Steve Lockhart; Catherine Callister; Kaitlyn Hoover; Ingrid A Binswanger Journal: J Gen Intern Med Date: 2022-01-03 Impact factor: 6.473